Francisco Leon - 10 Feb 2023 Form 4 Insider Report for Provention Bio, Inc.

Role
Chief Scientific Officer
Signature
/s/ Thierry Chauche, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
10 Feb 2023
Net transactions value
-$576,586
Form type
4
Filing time
14 Feb 2023, 18:19:38 UTC
Previous filing
20 Jan 2023
Next filing
14 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVB Common Stock Options Exercise $125,000 +50,000 +3.2% $2.50* 1,623,000 10 Feb 2023 Direct
transaction PRVB Common Stock Sale $505,605 -50,000 -3.1% $10.11 1,573,000 10 Feb 2023 Direct F1, F2
transaction PRVB Common Stock Options Exercise $64,962 +25,985 +1.7% $2.50* 1,598,985 13 Feb 2023 Direct
transaction PRVB Common Stock Sale $260,944 -25,985 -1.6% $10.04 1,573,000 13 Feb 2023 Direct F1, F3
holding PRVB Common Stock 1,000,000 10 Feb 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVB Stock Option (right to buy) Options Exercise $0 -50,000 -16% $0.000000 268,088 10 Feb 2023 Common Stock 50,000 $2.50 Direct F4
transaction PRVB Stock Option (right to buy) Options Exercise $0 -25,985 -9.7% $0.000000 242,103 13 Feb 2023 Common Stock 25,985 $2.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.29 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.42 per share, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
F4 The option is fully vested.